Kura Oncology Inc. (KURA)
NASDAQ: KURAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 10.67 0.00%
KURA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $949.21M
- EPS (TTM)
- -$3.37
- Dividend yield
- None
- 52-week range
- 7.36 – 13.90
- Day range
- 10.32 – 10.99
- Volume / Avg
- 1.10M / 1.78M
- Beta
- —
- Shares outstanding
- 88.96M
- Next earnings
- Nov 3, 2026
52-week range
KURA stock today
On Oct 7, KURA ended the session at $10.67, adding $0.14 (1.33%), versus the S&P 500's 0.22% decline. Shares are 23.2% below their 52-week high of $13.90, set on Aug 25, 2026 and 45.0% above the 52-week low of $7.36, in the middle of the past year's range. KURA is up 2.7% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 13.1%.
Kura Oncology has posted a net loss over the last twelve months (EPS of -$3.37), so its P/E ratio is not meaningful. Kura Oncology's next earnings report is expected on Nov 3, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Kura Oncology
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Earnings
Earnings history- Next report
- Nov 3, 2026
- EPS estimate
- $-0.83
Kura Oncology peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ANROAlto Neuroscience Inc. | 23.52 | -0.72% | $922.97M | vs KURA |
| MLTXMoonLake Immunotherapeutics Class A | 10.77 | -1.64% | $916.60M | vs KURA |
| SPTXSeaport Therapeutics Inc. | 17.93 | +3.22% | $959.80M | vs KURA |
| ANLAdlai Nortye Group Ltd. ADR | 14.05 | -2.84% | $904.79M | vs KURA |
| RIGLRigel Pharmaceuticals Inc. | 47.99 | +4.08% | $896.45M | vs KURA |
| CYRXCryoPort Inc. | 17.35 | -2.53% | $878.76M | vs KURA |
| ALMSAlumis Inc. | 6.77 | -2.31% | $876.28M | vs KURA |
| JBIOJade Biosciences Inc. | 13.77 | +2.68% | $875.74M | vs KURA |
Indexes, lists and sector
Largest Health Care stocks
Kura Oncology stock FAQ
What is Kura Oncology's stock price today?
KURA last traded at $10.67 as of Oct 7, 4:00 PM EDT, up 1.33% on the day. Prices are delayed at least 15 minutes.
When is Kura Oncology's next earnings date?
Kura Oncology is expected to report earnings on Tuesday, November 3, 2026. Analysts expect EPS of $-0.83.
What is the KURA 52-week high?
The 52-week high for KURA is $13.90 and the 52-week low is $7.36. The stock is currently 23.2% below its high.